omniture
PRESTIGE BIOPHARMA LTD.

Latest News

Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA

* Following approval by the European Commission, Prestige Biopharma's Herceptin biosimilar Tuznue...

2024-08-01 08:00 13670